Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Veteran Private Equity Investor Seth Harward Joins Siris as Managing Director – Business Development
WEST PALM BEACH, Fla., April 08, 2026 (GLOBE NEWSWIRE) -- Siris, a leading private equity firm targeting service companies that support critical technology infrastructure, today announced that...
-
BioStem Technologies to Showcase Innovation and Clinical Evidence at Symposium on Advanced Wound Care Spring 2026
-
NORWALK, Conn., April 08, 2026 (GLOBE NEWSWIRE) -- FactSet (NYSE:FDS | NASDAQ:FDS), a global financial digital platform and enterprise solutions provider, today announced that Joshua B. Warren has...
-
VANCOUVER, British Columbia, April 08, 2026 (GLOBE NEWSWIRE) -- Anfield Energy Inc. (TSX.V: AEC; NASDAQ: AEC; FRANKFURT: 0AD) (“Anfield” or the “Company”) is pleased to announce that, following...
-
VANCOUVER, British Columbia, April 08, 2026 (GLOBE NEWSWIRE) -- Xali Gold Corp. (TSXV:XGC) (“Xali Gold” or the “Company”) is pleased to announce that it has appointed Aran Gough as Senior Advisor –...
-
BRAMPTON, Ontario, April 08, 2026 (GLOBE NEWSWIRE) -- Loblaw Companies Limited (TSX: L) announced today that it will release its 2026 first quarter results on May 6th, 2026, at approximately 6:30...
-
MONTREAL, April 08, 2026 (GLOBE NEWSWIRE) -- NanoXplore Inc. (“NanoXplore”) (TSX: GRA and OTCQX: NNXPF), a world-leading graphene company, is pleased to announce Rocco Marinaccio President and CEO...
-
HOUSTON, April 08, 2026 (GLOBE NEWSWIRE) -- Analytic Stress Relieving, LLC (“Analytic Stress” or “the Company”), a provider of onsite heat treatment services, has announced Paul Stouffer as Chief...
-
NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today...
-
SYDNEY, April 08, 2026 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX: RAD, Nasdaq: RADX, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing...